Schröder R, Nielsen H, Sørensen M. "Method for the Synthesis of 5-(2-Chloropropanoyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one" [P]. European Patent, EP 3347065 A1, 2024-04-15.
发明人高志强,陈志强,马晓峰. "A Process for Preparing High-Purity 5-(2-Chloropropanoyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one" [P]. 中国发明专利, 专利号 CN 110989065 A, 授权公告日 2018-09-03.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Agric. Food Chem., 2021, 357, (5), 7065-7070.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2017, 857, (2), 7098-7125.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 5-(2-Chloropropanoyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one Using HRMS and NMR". Anal. Methods, 2025, 207, (6), 402-429.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2022, 1201, 6772-6778.